17-10035
CpG MethylQuest DNA Isolation Kit
The CpG MethylQuest DNA Isolation Kit allows for simple, effective & rapid enrichment of methylated DNA from genomic samples.
Select a Size
About This Item
species reactivity (predicted by homology)
all
manufacturer/tradename
Chemicon®
CpG MethylQuest®
application(s)
genomic analysis
shipped in
wet ice
General description
To evalute the methylation status of either a specific locus or an entire genome, the isolation and enrichment of methylated DNA can be a useful first step. To enable this enrichement, the CpG MethylQuest DNA Isolation Kit utilizes a high-affinity GST-MBD protein pre-bound to a magnetic bead.
This purified recombinant protein contains the methyl binding domain (MBD) of the mouse MBD2b protein fused to a glutathione-S-transferase protein (GST) from S. japonicum separated by a linker containing a thrombin cleavage site. The MBD from the MBD2b protein has the highest affinity among the known methyl CpG binding proteins for Me-CpG sites and the lowest cross reactivity with unmethylated CpG sequences (Fraga M.F., et al. (2003). Nuc. Acids Res, 31, 1765–1774). These properties allow for very specific enrichment of methylated regions.
In addition to its high affinity for methylated DNA, the CpG MethylQuest protein binds to methylated CpG regardless of sequence context. This is in contrast to isolation of methylated DNA using proteins such as MeCP2, which requires a run of A-Ts near a CpG site. This combination of sequence independent, high affinity binding to methylated CpG sites and extremely low affinity for non-methylated sites results in a greater number of methylated CpG sites being recognized allowing for comprehensive analysis of methylation patterns across the genome.
CpG MethylQuest Advantages
- Specific enrichment of methylated DNA fragments
- No detectable binding of unmethylated or hemimethylated regions
- Simple and fast 2-hour magnetic bead-based protocol
- GST-MBD2b capture protein pre-bound to magnetic beads for consistent results
- Reliable performance from 1 ng to 1 μg of DNA
- Elute ready-to-use DNA & avoid additional cleanup steps that reduce yields
Application
Epigenetics & Nuclear Function
Other Notes
CpG MethylQuest Magnetic Beads with pre-bound recombinant MBD protein
CpG MethylQuest Wash Buffer 1
CpG MethylQuest Wash Buffer 2
TE Buffer
Control HeLa DNA 110 ng, MseI cut, 2ng/µl
Positive Control Primers 10 µM each
Negative Control Primers 20 µM each
Legal Information
Disclaimer
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Signaling Product Guide: Antibodies, small molecule inhibitors, kits, assays and proteins for signaling research.
Cancer is a complex disease manifestation. At its core, it remains a disease of abnormal cellular proliferation and inappropriate gene expression. In the early days, carcinogenesis was viewed simply as resulting from a collection of genetic mutations that altered the gene expression of key oncogenic genes or tumor suppressor genes leading to uncontrolled growth and disease (Virani, S et al 2012). Today, however, research is showing that carcinogenesis results from the successive accumulation of heritable genetic and epigenetic changes. Moreover, the success in how we predict, treat and overcome cancer will likely involve not only understanding the consequences of direct genetic changes that can cause cancer, but also how the epigenetic and environmental changes cause cancer (Johnson C et al 2015; Waldmann T et al 2013). Epigenetics is the study of heritable gene expression as it relates to changes in DNA structure that are not tied to changes in DNA sequence but, instead, are tied to how the nucleic acid material is read or processed via the myriad of protein-protein, protein-nucleic acid, and nucleic acid-nucleic acid interactions that ultimately manifest themselves into a specific expression phenotype (Ngai SC et al 2012, Johnson C et al 2015). This review will discuss some of the principal aspects of epigenetic research and how they relate to our current understanding of carcinogenesis. Because epigenetics affects phenotype and changes in epigenetics are thought to be key to environmental adaptability and thus may in fact be reversed or manipulated, understanding the integration of experimental and epidemiologic science surrounding cancer and its many manifestations should lead to more effective cancer prognostics as well as treatments (Virani S et al 2012).
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service